NCT07540143Recruiting
The REACH-OUT Trial
A Technology-based, Primary Care Strategy to Optimize Blood Pressure Before Pregnancy: The REACH-OUT Trial
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
Test the effectiveness of a technology-enabled strategy to optimize blood pressure among reproductive-aged women with hypertension receiving care in Federally Qualified Health Centers.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 350 (estimated)
- First submitted
- 13 Apr 2026
- Start date
- 16 Jun 2026
- Primary completion date
- 1 Apr 2029
- Lead sponsor
- Northwestern University
- Diseases
- High blood pressure
- NCT number
- NCT07540143
What you commit to
- Study type: Interventional
- Planned participants: 350
- From 16 Jun 2026 to the primary completion date, 1 Apr 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- severe, uncorrectable vision, hearing, or cognitive impairment that would preclude study consent or participation
Other
- not pregnant or within 3 months postpartum
Who the study is looking for
- biologically female
- age 18-44
- English or Spanish-speaking
- prescribed an antiHTN
- have a systolic BP \>140 or diastolic BP\>90 at their index visit
- have access to the internet
Age in the registry: 18 years to 44 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northwestern University Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.